Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats

Indian Journal of Pharmacology

Volumn 44, Issue 6, 2012, Pages 688-693

  Nade, Vandana S ^a   Kawale, Laxman A ^a   Todmal, Umesh B ^a   Tajanpure, Anjali B ^a  

^a Department of Pharmacology   (India)

Author keywords

Bromocriptine; fructose; metabolic syndrome

Indexed keywords

ACETYLCHOLINE; ADRENALIN; BROMOCRIPTINE MESILATE; CHOLESTEROL; FRUCTOSE; INSULIN; NORADRENALIN; PHENYLEPHRINE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SYSTOLIC HYPERTENSION; TREATMENT DURATION; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION; WEIGHT GAIN;

ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; BLOOD PRESSURE; BROMOCRIPTINE; CARDIOVASCULAR DISEASES; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DIET; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; FRUCTOSE; HEART RATE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METABOLIC SYNDROME X; METFORMIN; MYOCARDIUM; RATS; RATS, WISTAR; THIAZOLIDINEDIONES; TRIGLYCERIDES; VASODILATION;

EID: 84870038355     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.103248     Document Type: Article

References (19)

1. D'Souza A, Hussain M, Howarth FC, Woods NM, Bidasee K, Sing J. Pathogenesis and pathophysiology of accelerated atherosclerosis in diabetic heart. Mol Cell Biochem 2009;9:148-58.
2. Wild SH, Byrne CD. The Global burden of the metabolic syndrome and its consequences for diabetes and cardiovascular disease. In: Wild SH, Byrne CD, editors. The metabolic syndrome. 2nd ed. Chichester, UK: John Wiley and Sons Ltd; 2005. p. 2-5.
3. Konrad D, Rudich A, Klip A. Insulin mediated regulation of glucose metabolism. In: Kumar S, Rahilly SO, editors. Insulin resistance: Insulin action and its disturbances in disease. 2nded. Chichester, UK: John Wiley and Sons Ltd; 2005. p. 64-6.
4. MacLean PS, Zheng D, Jones JP, Olson AL, Dohm GL. Exercise-induced transcription of the muscle glucose transporter (GLUT 4) gene. Biochem Biophys Res Commun 2002;292:409-14.
5. John BB. Progressive use of medical therapies in type 2 diabetes. Diabetes Spectr 2000;13:211-16.
6. Chan M. Reducing cost-related medication no adherence in patients with diabetes. Drug Benefit Trends 2010;22:67-71.
7. Mahajan R. Bromocriptinemesylate: FDA-approved novel treatment for type-2 diabetes. Indian J Pharmacol 2009;41:197-8.
8. Vogel HG. Drug discovery and evaluation: Pharmacological Assay. 2nd ed. New York, Berlin Heidelberg: Springer-Verlag; 2002. p. 176.
9. Hwang IS, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987;10:512-6.
10. Balaraman R, Hingorani H, Rathod SP. Studies on the antihypertensive effect of abana in rats. Indian J Pharmacol 1993;25:209-14.
11. Honda H, Ushijima D. A regional variation of acetylcholine-induced relaxation in different segments of rat aorta. Physiol Behav 1998;63:55-8.
12. Lee MS, Choudhury RP. Vascular Biology of the metabolic syndrome. In: Krentz AJ, Wong ND, editors. Metabolic syndrome and cardiovascular disease, epidemology, assessment and management. New York: Informa Healthcare Inc.; 2007. p. 79-81.
13. Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002;76:911-22.
14. Basciano H, Federico L, Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005;2:1-14.
15. Volkova NB, Deedwania PC. Dyslipidemia in the metabolic syndrome. In: Krentz AJ, Wong ND, editors. Metabolic syndrome and cardiovascular disease, Epidemology, assessment, and management. New York: Informa Healthcare USA, Inc.; 2007. p. 191-6.
16. Davis LM, Pei Z, Trush MA, Cheskin LJ, Contoreggi C, McCullougu K, et al. Bromocriptine reduces steatosis in obese rodent models. J Hepatol 2006;45:439-44.
17. Reaven GM, Hoffman BB. Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 1988;12:129-32.
18. Defronzo RA, Goldberg M, Agus Z. The effect of glucose and insulin on renal electrolyte transport. J Clin Invest 1976;58:83-90.
19. Katakam PV, Ujhelyi MR, Hoenig ME, Miller AW. Endothelial dysfunction precedes hypertension in diet-induced insulin resistance. Am J Physiol 1998;275:R788-92.